Aelis Farma Will Participate in the Addiction 2022 Conference Dedicated to Innovation in the Treatment of Addictions
BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – ticker: AELIS, PEA-PME eligible), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, today announces its participation…